Accordingly, substantial interest is directed toward understanding the genetic and metabolic factors that infl uence HDL-C levels. It is well documented that endothelial lipase (EL) is an important determinant of HDL metabolism in both humans and rodents. In mice, overexpression of EL leads to signifi cantly reduced plasma HDL-C ( 2-4 ) whereas decreased EL activity through either gene deletion ( 3,5 ) or antibody inhibition ( 6 ) leads to increased HDL-C. In humans, plasma EL concentrations are inversely correlated with HDL-C levels ( 7 ) and rare missense mutations in EL are more common in humans with high HDL-C ( 8 ).EL is a member of the triglyceride lipase gene family that also includes pancreatic lipase, lipoprotein lipase, and hepatic lipase ( 2 ). Unlike other members of this lipase family, EL exhibits relatively high phospholipase activity and low triglyceride lipase activity, and its favored substrate is HDL ( 9 ). Turnover studies in mice with adenoviral vector-mediated overexpression indicate that EL hydrolyzes HDL phospholipids in vivo and increases the fractional catabolic rate of HDL apolipoproteins in a dose-dependent manner ( 4 ). Based on studies carried out in vitro, EL phospholipase activity remodels HDL to smaller particles without dissociating lipid-poor apoA-I ( 10 ). This is in contrast to what occurs with hepatic lipase, where triglyceride hydrolysis of core lipids leads to shedding of lipid-poor apoA-I from destabilized HDL particles ( 11 ).Evidence suggests that EL is increased in humans during infl ammation, a condition associated with reduced HDL-C ( 12, 13 ). In cross-sectional studies, plasma markers of infl ammation are strongly associated with plasma levels of EL ( 14,15 ). EL concentrations are also associated with It has been recognized for decades that plasma concentrations of HDL cholesterol (HDL-C) are inversely related to the risk of atherosclerotic cardiovascular disease ( 1 ).
Abstract Infl ammation is associated with signifi cant decreases in plasma HDL-cholesterol (HDL-C) and apoA-I levels. Endothelial lipase (EL) is known to be an important determinant of HDL-C in mice and